Insider · CIK 0001992908
Robert A. Lenz
Files at NMRA (Neumora Therapeutics, Inc.). First filing Oct 11, 2024, latest Oct 11, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NMRA: Neumora Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | Neumora Therapeutics, Inc. | $208k 13,823 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2024 | NMRA Neumora Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -5,563 | $15.01 | $84k | 322,966 | Oct 11, 2024 |
| Oct 10, 2024 | NMRA Neumora Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -8,260 | $15.09 | $125k | 314,706 | Oct 11, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.